Limitations in current clinical trials on renal denervation
نویسندگان
چکیده
منابع مشابه
Renal denervation – current evidence and perspectives
Clinical trials have demonstrated that catheter-based renal denervation (RDN) reduces blood pressure and improves blood pressure control in patients with resistant hypertension. The follow-up data indicate that the blood pressure lowering effect of the procedure may last for up to 36 months. Despite the fact that RDN is a growing and promising technique, still more data from clinical trials are...
متن کاملLimitations of clinical trials in surgery.
One of the key elements of improving the health care system in the world is to respect the recommendations resulting from the socalled evidence-based medicine (EBM). Improvement considering clinical decision-making in medicine, including surgery may be attained when best evidence based medicine (EBM) will be combined with the following: – clinical experience, – medical knowledge in the field of...
متن کاملCurrent Clinical Trials in Neuroblastoma
Neuroblastoma is a pediatric malignant tumor of the postganglionic sympathetic nervous system that usually develops in the adrenal gland or in nonadrenal abdominal or thoracic sites.[1] It is the most common malignancy in infants and the most common extracranial solid tumor of childhood, with approximately 650 cases diagnosed annually in the United States.[2] The dramatic age-related survival d...
متن کاملRenal Sympathetic Denervation for Resistant Hypertension Treatment - Current Perspectives
The authors review the concept of resistant hypertension and the involvement of the sympathetic nervous system in hypertension as a rational basis for the technique of renal sympathetic denervation (RSD) performed percutaneously. This revision is the result of an active search for scientific articles with the term "renal denervation" in the Medline and PubMed databases. The techniques and devic...
متن کاملRenal Denervation
Type 2 diabetes mellitus (T2DM) is a group of metabolic diseases of multiple etiologies. Although great progress has been made, researchers are still working on the pathogenesis of T2DM and how to best use the treatments available. Aside from several novel pharmacological approaches, catheter-based sympathetic renal denervation (RDN) has gained a significant role in resistant hypertension, as w...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Cardiology
سال: 2014
ISSN: 0167-5273
DOI: 10.1016/j.ijcard.2014.04.054